Skip to main content
. Author manuscript; available in PMC: 2009 Oct 27.
Published in final edited form as: J Allergy Clin Immunol. 2007 Sep;120(3):594–601. doi: 10.1016/j.jaci.2007.06.015

Figure 1.

Figure 1

Effect of omalizumab on peripheral blood eosinophil counts

Peripheral blood absolute eosinophil counts were determined at baseline (week 0) and every 2 weeks thereafter for the duration of the study. The actual values for each time point (A), as well as the value as a percentage of the pre-omalizumab baseline (B) are shown.